Finance

Lists
Why is 300562 down 3.25%?
Dive Deeper
300562:SHE
Guangdong Transtek Medicl Elctrncs CoLtd
CN¥ 13.41
-3.25%
(-0.45) 1D
10-р сарын 15, 15:04:40 (GMT+8)  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300562...
Open
CN¥ 13.50
High
CN¥ 13.80
Low
CN¥ 13.35
Mkt. cap
3.15 тэрбум
Avg. vol.
16.71 сая
Volume
8.70 сая
Dividend
1.94%
Quarterly dividend
CN¥ 0.06
Ex-dividend date
2026 оны 10-р сарын 15
P/E ratio
29.36
52-wk high
CN¥ 19.54
52-wk low
CN¥ 11.32
EPS
CN¥ 0.46
Shares outstanding
218.93 сая
No. of employees
1 мян.
Open
CN¥ 13.50
High
CN¥ 13.80
Low
CN¥ 13.35
Mkt. cap
3.15 тэрбум
Avg. vol.
16.71 сая
Volume
8.70 сая
Dividend
1.94%
Quarterly dividend
CN¥ 0.06
Ex-dividend date
2026 оны 10-р сарын 15
P/E ratio
29.36
52-wk high
CN¥ 19.54
52-wk low
CN¥ 11.32
EPS
CN¥ 0.46
Shares outstanding
218.93 сая
No. of employees
1 мян.
News stories
From web sources and news partners
Profile
Transtek Medical, commonly known as Lifesense, fully referred to as Guangdong Transtek Medical Electronics Co., Ltd., is a Chinese wearable device maker that also focuses on the field of mobile health. The company was founded by Weichao Pan in 2002, with its main products being home medical and health electronics, such as scales, smart bracelets and blood pressure monitors. According to IDC, the company shipped one million units of wearables in the second quarter of 2016, ranking fifth in the global wearable devices market, coming in behind Fitbit, Apple and Garmin. Transtek's IPO application was approved by the CSRC in October 2016. On November 16, it landed on the Shenzhen Stock Exchange with the ticker symbol "300562.SZ". Wikipedia
About Guangdong Transtek Medicl Elctrncs CoLtd
CEO-
Employees1.09 мян
Founded2002 оны 7-р сарын 18
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
235.76 сая
229.08 сая
283.74 сая
250.69 сая
Cost of goods sold
149.14 сая
152.94 сая
176.58 сая
166.11 сая
Cost of revenue
149.14 сая
152.94 сая
176.58 сая
166.11 сая
Research and development expenses
20.36 сая
24.79 сая
26.69 сая
23.33 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
41.57 сая
26.45 сая
41.12 сая
21.85 сая
Operating expense
58.96 сая
52.61 сая
71.19 сая
48.25 сая
Total operating expenses
208.10 сая
205.55 сая
247.78 сая
214.35 сая
Operating income
27.66 сая
23.53 сая
35.96 сая
36.34 сая
Other non operating income
-3.39 сая
2.22 сая
-4.58 сая
3.96 сая
EBT including unusual items
23.63 сая
16.59 сая
32.82 сая
31.28 сая
EBT excluding unusual items
25.70 сая
24.73 сая
31.68 сая
34.21 сая
Income tax expense
118.51 мян
1.08 сая
931.10 мян
3.84 сая
Effective tax rate
0.50%
6.54%
2.84%
12.27%
Other operating expenses
-1.92 сая
3.87 сая
1.19 сая
2.80 сая
Net income
23.39 сая
16.32 сая
32.07 сая
27.96 сая
Net profit margin
9.92%
7.12%
11.30%
11.15%
Earnings per share
-
-
-
-
Interest and investment income
3.39 сая
2.85 сая
330.33 мян
3.10 сая
Interest expense
-1.40 сая
-
-37.02 мян
-57.71 мян
Net interest expenses
1.99 сая
2.85 сая
293.32 мян
3.05 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
32.45 сая
28.29 сая
40.73 сая
41.00 сая
Gain or loss from assets sale
-150.13 мян
26.11 мян
-
-1.36 сая
AI content may include mistakes. Learn more
Google аппс